Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
I3Y-MC-JPEI
Phase 1 other active
Quick answer
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment for Prostatic Neoplasms is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Prostatic Neoplasms
- Phase
- Phase 1
- Modality
- other
- Status
- active